)
Aprea Therapeutics (APRE) investor relations material
Aprea Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order by the CEO, with all directors and the independent auditor present virtually.
Virtual format enabled broader stockholder participation and engagement.
Agenda included director elections, auditor ratification, reverse stock split, executive compensation, say-on-pay frequency, and potential adjournment.
Board and executive committee updates
Three current directors nominated for re-election to serve until the 2029 annual meeting.
All directors attended virtually, and the independent auditor was available for questions.
Shareholder proposals
Proposals included director elections, auditor ratification, reverse stock split authorization, executive compensation approval, say-on-pay frequency, and adjournment if needed.
- Early data show promising efficacy and safety for a next-gen WEE1 inhibitor in biomarker-driven cancer therapy.APRE
Oppenheimer 36th Annual Healthcare Life Sciences Conference1 Jul 2026 - $30M financing closed, cash runway into 2028, with promising APR-1051 trial results.APRE
Q1 202613 May 2026 - Key votes include director elections, auditor ratification, and a reverse stock split.APRE
Proxy filing30 Apr 2026 - Key votes include director elections, a reverse stock split, and annual say-on-pay, all Board-recommended.APRE
Proxy filing30 Apr 2026 - Registering 74M+ shares for resale, with proceeds from warrants funding clinical trials amid going concern risks.APRE
Registration filing23 Apr 2026 - APR-1051 demonstrates early efficacy and safety as a selective WEE1 inhibitor in targeted cancers.APRE
Corporate presentation20 Apr 2026 - Key votes include director elections, a reverse stock split, and executive compensation approval.APRE
Proxy filing20 Apr 2026 - Shelf registration filed amid auditor's going concern warning and strong scientific leadership.APRE
Registration Filing17 Mar 2026 - Clinical progress and improved financials position the company for key milestones in 2026.APRE
Q4 202516 Mar 2026
Next Aprea Therapeutics earnings date
Next Aprea Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage